Katriina Vuolteenaho

Activities

Activities per year 1999 2009 2010 2011 2012 2013 2016 2017 2018 2023

• 156 Conference presentation
• 16 Invited lecture
• 10 Reviewer of Scientific Journal
• 7 Position of trust in an academic community
• 22 More
  • 6 Regular membership of a society or network
  • 4 Pre-examination of dissertation or acting as opponent to doctoral students
  • 4 Supervisor of licentiate candidate in medicine
  • 2 Supervisor of doctoral candidate
  • 2 Supervisor of licentiate candidate
  • 2 Position of trust in a funding organization
  • 1 Statement of assessment of docentship
  • 1 Supervisor of master student

Activities per year

Search results

• Human osteoarthritic chondrocytes express nineteen different TRP-genes – TRPA1 and TRPM8 as potential drug targets

  Leevi Halonen (Speaker), Antti Pemmari (Contributor), Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  2 Jul 2023 → 7 Jul 2023

  Activity: Talk or presentation › Conference presentation

• Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets

  Antti Laurikka (Speaker), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Jari Laurikka (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  2 Jul 2023 → 7 Jul 2023

  Activity: Talk or presentation › Conference presentation

• Meteorin-like protein as a novel factor and potential drug target in osteoarthritis

  Katriina Vuolteenaho (Speaker), Anna Koskinen-Kolasa (Contributor), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Teemu Moilanen (Contributor) & Eeva Moilanen (Contributor)

  2 Jul 2023

  Activity: Talk or presentation › Conference presentation

• cAMP enhancing drugs salbutamol and rolipram promote alternative macrophage activation through MKP-1 in murine macrophages

  Tiina Lehtola (Contributor), Elina Nummenmaa (Contributor), Tiina Leppänen (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  2 Jul 2023 → 7 Jul 2023

  Activity: Talk or presentation › Conference presentation

• Genome wide analysis of gene expression changes in atrial myocardium caused by coronary artery bypass grafting surgery with cardiopulmonary bypass: towards understanding mechanisms and therapeutic targets

  Antti Laurikka (Contributor), Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Jari Laurikka (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  22 Mar 2023 → 24 Mar 2023

  Activity: Talk or presentation › Conference presentation

• The glucocorticoid dexamethasone alleviates allergic inflammation through an MKP-1 dependent mechanism

  Tiina Lehtola (Contributor), Elina Nummenmaa (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  22 Mar 2023 → 24 Mar 2023

  Activity: Talk or presentation › Conference presentation

• Human osteoarthritic chondrocytes express nineteen different TRP-genes – TRPA1 and TRPM8 as potential drug targets

  Katriina Vuolteenaho (Examiner)

  2023

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate

• Inflammatory glycoprotein YKL-40 is elevated after coronary artery bypass surgery and correlates with leukocyte chemotaxis and myocardial injury, a pilot study

  Antti Laurikka (Speaker), Katriina Vuolteenaho (Contributor), Vesa Toikkanen (Contributor), Timo Rinne (Contributor), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Matti Tarkka (Contributor), Jari Laurikka (Contributor) & Eeva Moilanen (Contributor)

  24 Nov 2022 → 25 Nov 2022

  Activity: Talk or presentation › Conference presentation

• The glucocorticoid dexamethasone alleviates acute allergic inflammatory reaction through an MKP-1 dependent mechanism

  Tiina Lehtola (Speaker), Elina Nummenmaa (Contributor), Riina Nieminen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  24 Nov 2022 → 25 Nov 2022

  Activity: Talk or presentation › Conference presentation

• Pinosylvin shifts macrophage polarization to support resolution of inflammation

  Katriina Vuolteenaho (Examiner)

  2022

  Activity: Evaluation, examination and supervision › Supervisor of licentiate candidate

• TRPA1 as a factor in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates fibroblast growth factor-2 expression in chondrocytes

  Elina Nummenmaa (Speaker), Mari Hämäläinen (Contributor), Antti Pemmari (Contributor), Lauri Moilanen (Contributor), Riina Nieminen (Contributor), Teemu Moilanen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  25 Nov 2021 → 26 Nov 2021

  Activity: Talk or presentation › Conference presentation

• Pinosylvin shifts macrophage polarization to support resolution of inflammation

  Konsta Kivimäki (Speaker), Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Katriina Vuolteenaho (Contributor) & Eeva Moilanen (Contributor)

  25 Nov 2021 → 26 Nov 2021

  Activity: Talk or presentation › Conference presentation

• Suomen Farmakologiyhdistys ry, johtokunnan jäsen (External organisation)

  Katriina Vuolteenaho (Member)

  1 Jan 2021 → …

  Activity: Membership › Position of trust in an academic community

• Väitöskirjan esitarkastus

  Katriina Vuolteenaho (Pre-examiner or opponent of dissertation)

  17 Apr 2020

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Suomen Farmakologiyhdistys ry, sihteeri (External organisation)

  Katriina Vuolteenaho (Position of trust)

  1 Jan 2020 → 31 Dec 2020

  Activity: Membership › Position of trust in an academic community

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), E Moilanen (Contributor), LJ Moilanen (Contributor), R Nieminen (Contributor), K Vuolteenaho (Contributor) & T Moilanen (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) as a factor and drug target in osteoarthritis: TRPA1 mediates fibroblast growth factor 2 expression in chondrocytes

  Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)

  2 May 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  A Pemmari (Contributor), L Tuure (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  2 May 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates fibroblast growth factor-2 (FGF-2) expression in chondrocytes

  Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates FGF-2 expression in chondrocytes

  Elina Nummenmaa (Speaker), Mari Hämäläinen (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker) & Katriina Vuolteenaho (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  A Pemmari (Speaker), L Tuure (Speaker), M Hämäläinen (Speaker), T Leppänen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• Adipokines and disease activity in patients with newly diagnosed inflammatory joint diseases

  A Kononoff (Speaker), K Vuolteenaho (Speaker), M Hämäläinen (Speaker), H Kautiainen (Speaker), P Elfving (Speaker), E Savolainen (Speaker), L Arstila (Speaker), H Niinisalo (Speaker), J Rutanen (Speaker), O Marjoniemi (Speaker), E Moilanen (Speaker) & O Kaipiainen-Seppänen (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• Pirkanmaan sairaanhoitopiirin kuntayhtymä, Tampereen yliopistollisen sairaalan erityisvastuualueen alueellinen eettinen toimikunta, jäsen (External organisation)

  Katriina Vuolteenaho (Member)

  1 Jan 2019 → 12 Sept 2021

  Activity: Membership › Regular membership of a society or network

• Journal of Functional Foods (Journal)

  Katriina Vuolteenaho (Reviewer)

  2019

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes

  Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor) & Katriina Vuolteenaho (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis

  Mari Hämäläinen (Contributor), Lauri Lehtimäki (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Elina Nummenmaa (Contributor) & Katriina Vuolteenaho (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Obesity and adipokines in osteoarthritis

  K Vuolteenaho (Keynote speaker)

  8 Sep 2018

  Activity: Talk or presentation › Invited lecture

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis

  A Pemmari (Speaker), T Syvänen (Speaker), M Hämäläinen (Speaker), T Moilanen (Speaker), K Vuolteenaho (Speaker) & E Moilanen (Speaker)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a factor in osteoarthritis: TRPA1 (Transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes

  E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), L Moilanen (Contributor), R Nieminen (Contributor), T Moilanen (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a novel factor in osteoarthritis: TRPA1 ion channel mediates MIA-induced acute inflammation and contributes to the development of cartilage degradation and joint pain in the MIA-model of osteoarthritis

  Mari Hämäläinen (Speaker), Lauri Männistö (Speaker), Eeva Moilanen (Speaker), Riina Nieminen (Speaker), Elina Nummenmaa (Speaker) & Katriina Vuolteenaho (Speaker)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  M Scotece (Contributor), A Koskinen-Kolasa (Contributor), A Pemmari (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)

  5 Sept 2018

  Activity: Talk or presentation › Conference presentation

• Väitöskirjan esitarkastus

  Katriina Vuolteenaho (Pre-examiner or opponent of dissertation)

  30 Aug 2018

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  26 Apr 2018

  Activity: Talk or presentation › Conference presentation

• TRPA1 as a factor and drug target in osteoarthritis: TRPA1 (transient receptor potential ankyrin 1) mediates interleukin-6 expression in chondrocytes

  Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)

  26 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis

  Antti Pemmari (Speaker), Mari Hämäläinen (Speaker), Tiina Leppänen (Speaker), Eeva Moilanen (Speaker) & Katriina Vuolteenaho (Speaker)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis (OA): Retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in OA patients

  M Scotece (Contributor), A Koskinen-Kolasa (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates interleukin-6 expression in chondrocytes

  Elina Nummenmaa (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor), Riina Nieminen (Contributor), Antti Pemmari (Contributor) & Katriina Vuolteenaho (Contributor)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients

  M Scotece (Contributor), A Koskinen-Kolasa (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)

  21 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes

  E Nummenmaa (Contributor), M Hämäläinen (Contributor), A Pemmari (Contributor), LJ Moilanen (Contributor), RM Nieminen (Contributor), T Moilanen (Contributor), K Vuolteenaho (Contributor) & E Moilanen (Contributor)

  21 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Väitöskirjan esitarkastus

  Katriina Vuolteenaho (Pre-examiner or opponent of dissertation)

  29 Jan 2018

  Activity: Evaluation, examination and supervision › Pre-examination of dissertation or acting as opponent to doctoral students

• Transient receptor potential ankyrin 1 (TRPA1) mediates IL-6 expression in chondrocytes

  E Nummenmaa (Speaker), M Hämäläinen (Speaker), A Pemmari (Speaker), L Moilanen (Speaker), R Nieminen (Speaker), T Moilanen (Speaker), K Vuolteenaho (Speaker) & E Moilanen (Speaker)

  25 Jan 2018

  Activity: Talk or presentation › Conference presentation

• Adipokine retinol binding protein 4 is expressed in chondrocytes and correlates with matrix metalloproteinases in osteoarthritis patients

  Eeva Moilanen (Speaker) & Katriina Vuolteenaho (Speaker)

  25 Jan 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Speaker), T Leppänen (Speaker), M Hämäläinen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker), R Nieminen (Speaker) & E Moilanen (Speaker)

  25 Jan 2018

  Activity: Talk or presentation › Conference presentation

• Opinnäytetöiden ohjaus, Väitöskirja: Adipocytokines in osteoarthritis

  Katriina Vuolteenaho (Examiner)

  2018 → …

  Activity: Evaluation, examination and supervision › Supervisor of doctoral candidate

• High synovial fluid interleukin-6 levels are associated with increased matrix metalloproteinase levels and severe radiographic changes in osteoarthritis patients

  K Vuolteenaho (Contributor), A Koskinen-Kolasa (Contributor), M Laavola (Contributor), R Nieminen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  26 Oct 2017

  Activity: Talk or presentation › Conference presentation